Your browser doesn't support javascript.
loading
Molecular subtype-specific efficacy of anti-EGFR therapy in colorectal cancer is dependent on the chemotherapy backbone.
Ten Hoorn, Sanne; Sommeijer, Dirkje W; Elliott, Faye; Fisher, David; de Back, Tim R; Trinh, Anne; Koens, Lianne; Maughan, Tim; Seligmann, Jenny; Seymour, Matthew T; Quirke, Phil; Adams, Richard; Richman, Susan D; Punt, Cornelis J A; Vermeulen, Louis.
Affiliation
  • Ten Hoorn S; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Sommeijer DW; Oncode Institute, Amsterdam UMC, Amsterdam, The Netherlands.
  • Elliott F; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Fisher D; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • de Back TR; Flevohospital, Department of Internal Medicine, Almere, The Netherlands.
  • Trinh A; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.
  • Koens L; MRC Clinical Trials Unit, University College London, London, UK.
  • Maughan T; Amsterdam UMC, University of Amsterdam, LEXOR, Center for Experimental and Molecular Medicine, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Seligmann J; Oncode Institute, Amsterdam UMC, Amsterdam, The Netherlands.
  • Seymour MT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Quirke P; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Adams R; Department of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Richman SD; Department of Oncology, University of Oxford, Oxford, UK.
  • Punt CJA; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.
  • Vermeulen L; Leeds Institute of Medical Research at St James's, University of Leeds, St James's University Hospital, Leeds, UK.
Br J Cancer ; 125(8): 1080-1088, 2021 10.
Article in En | MEDLINE | ID: mdl-34253874
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Protein Kinase Inhibitors / Irinotecan / Oxaliplatin Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Protein Kinase Inhibitors / Irinotecan / Oxaliplatin Type of study: Observational_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Br J Cancer Year: 2021 Document type: Article Affiliation country: